Table 1.
Patients characteristics showing tumor type, and MIB-1 index.
| Patient | Sex | Age (years) | Tumor type (Immunohistochemistry) | MIB-1 (%) |
|---|---|---|---|---|
| 1 | M | 45 | LH | 2 |
| 2 | M | 82 | FSH | 3 |
| 3 | F | 67 | FSH | 1 |
| 4 | F | 64 | FSH | 1 |
| 5 | M | 62 | FSH | 1 |
| 6 | M | 46 | FSH | 2-3 |
| 7 | M | 66 | LH/FSH | 2 |
| 8 | M | 68 | LH/FSH | 1 |
| 9 | M | 62 | LH/FSH | 2 |
| 10 | F | 63 | LH/FSH | 2 |
| 11 | F | 66 | LH/FSH | 3 |
| 12 | F | 25 | LH/FSH | 2 |
| 13 | F | 54 | LH/FSH | 1 |
| 14 | M | 53 | LH/FSH | 2 |
| 15 | M | 61 | LH/FSH | 1-2 |
| 16 | M | 47 | LH/FSH | 1 |
| 17 | F | 65 | LH/FSH | 1 |
| 18 | M | 66 | PRL | 1 |
| 19 | F | 26 | PRL | 1 |
| 20 | M | 51 | PRL | 1 |
| 21 | F | 49 | PRL | 3-4 |
| 22 | F | 34 | PRL | 2 |
| 23 | F | 18 | PRL | 2-3 |
| 24 | F | 36 | PRL | 3 |
| 25 | F | 22 | PRL | NA |
| 26 | F | 50 | PRL | 1 |
| 27 | F | 37 | PRL | 1-2 |
| 28 | F | 45 | PRL | 2 |
| 29 | F | 37 | ACTH | 1 |
| 30 | M | 70 | ACTH | NS |
| 31 | F | 32 | ACTH | 2-3 |
| 32 | F | 54 | ACTH | 2-4 |
| 33 | M | 61 | Mixed (FSH, PRL) | 1 |
| 34 | F | 49 | Mixed (FSH, PRL, TSH) | 1 |
| 35 | F | 62 | Mixed (PRL, GH) | 2 |
| 36 | F | 68 | Mixed (GH, LH, FSH, PRL) | 1 |
| 37 | F | 49 | Mixed (ACTH, LH, FSH) | 3 |
| 38 | F | 48 | Mixed (GH, PRL) | 2-6 |
| 39 | M | 73 | Mixed (GH, ACTH, PRL) | 1 |
| 40 | M | 45 | Mixed (ACTH, LH, FSH) | 1-2 |
| 41 | F | 46 | Negative | 1 |
| 42 | M | 37 | Negative | 3 |
| 43 | F | 39 | Negative | 1 |
| 44 | M | 42 | Negative | 1 |
| 45 | F | 75 | Negative | 1 |
Negative, negative for all of the hormones secreted by pituitary adenomas; NA, not available; NS, no staining.